# Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants

> **NCT02969746** · PHASE4 · WITHDRAWN · sponsor: **University Hospital, Angers**

## Conditions studied

- Anticoagulants; Circulating, Hemorrhagic Disorder

## Interventions

- **DRUG:** Activated Charcoal

## Key facts

- **NCT ID:** NCT02969746
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-07-18
- **Primary completion:** 2018-09
- **Final completion:** 2024-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Feasibility issues, difficulties in the patient pathway, advances in knowledge
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02969746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02969746, "Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02969746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*